Endonovo Therapeutics, Inc.
Viés de alta

$ENDV Alerted at .0150 Currently .0850 4th Major Leg up Starting

255
1. Won their Injunction
2. PreClinical Trials for its Immunotronics Platform
3. Filed for Orphan Drug Status
4. Over 20 patents
5. Form 4s filed by insiders
6. Converts being bought by Company and Institutions
7. Uplistment
8. President and CEO has been filing form 4's everyday so far the past couple weeks

Aviso legal

As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.